Cargando…
Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo
AIMS/HYPOTHESIS: Obesity causes type 2 diabetes leading to vascular dysfunction and finally renal end-organ damage. Vascular smooth muscle (VSM) EGF receptor (EGFR) modulates vascular wall homeostasis in part via serum response factor (SRF), a major regulator of VSM differentiation and a sensor for...
Autores principales: | Stern, Christian, Schreier, Barbara, Nolze, Alexander, Rabe, Sindy, Mildenberger, Sigrid, Gekle, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476975/ https://www.ncbi.nlm.nih.gov/pubmed/32548701 http://dx.doi.org/10.1007/s00125-020-05187-4 |
Ejemplares similares
-
Endothelial epidermal growth factor receptor is of minor importance for vascular and renal function and obesity-induced dysfunction in mice
por: Schreier, Barbara, et al.
Publicado: (2021) -
Assessment of the Role of Endothelial and Vascular Smooth Muscle EGFR for Acute Blood Pressure Effects of Angiotensin II and Adrenergic Stimulation in Obese Mice
por: Schreier, Barbara, et al.
Publicado: (2023) -
Transcriptional impact of EGFR activation in human female vascular smooth muscle cells
por: Dubourg, Virginie, et al.
Publicado: (2023) -
The Functional Interaction of EGFR with AT1R or TP in Primary Vascular Smooth Muscle Cells Triggers a Synergistic Regulation of Gene Expression
por: Dubourg, Virginie, et al.
Publicado: (2022) -
Synergy of epidermal growth factor (EGFR) and angiotensin II (AT1R) receptor determines composition and temporal pattern of transcriptome variation
por: Schreier, Barbara, et al.
Publicado: (2021)